Table of Contents
ISRN Hematology
Volume 2012 (2012), Article ID 718671, 5 pages
http://dx.doi.org/10.5402/2012/718671
Research Article

Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections

Department of Pathology and Transfusion Medicine, Santokba Durlabhji Memorial Hospital & Research Institute, Rajasthan, Jaipur 302015, India

Received 18 June 2012; Accepted 8 August 2012

Academic Editors: A. Bosly, A. Gatt, A. Pekrun, and A. M. Will

Copyright © 2012 Rohit Jain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Jain and G. Gupta, “Family/friend donors are not true voluntary donors,” Asian Journal of Transfusion Science(, vol. 6, pp. 29–31, 2012. View at Publisher · View at Google Scholar
  2. “Voluntary blood donation programme—an operational guideline,” National AIDS Control Organisation, Ministry of Health and Family Welfare Government of India, New Delhi, India, 2007, http://www.nacoonline.org/.
  3. “Annual Report,” Department of AIDS Control, Ministry of Health and Family Welfare, Government of India, New Delhi, India, 2009-10, http://www.nacoonline.org/.
  4. “HIV AIDS in South-East Asia Region: progress report 2010,” WHO Regional Office for South-East Asia, December 2010, http://www.who.int/hiv/pub/surveillance/searo_2010/en/index.html.
  5. M. Meena, T. Jindal, and A. Hazarika, “Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five-year study,” Transfusion, vol. 51, no. 1, pp. 198–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Jha, R. Kumar, A. Khera et al., “HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes,” BMJ, vol. 340, p. c621, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Chattoraj, R. Behl, and V. K. Kataria, “Infectious disease markers in blood donors,” Medical Journal Armed Forces India, vol. 64, no. 1, pp. 33–35, 2008. View at Google Scholar · View at Scopus
  8. M. El Ekiaby, N. Lelie, and J. P. Allain, “Nucleic acid testing (NAT) in high prevalence-low resource settings,” Biologicals, vol. 38, no. 1, pp. 59–64, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. N. Makroo, N. Choudhury, L. Jagannathan et al., “Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of Human immunodeficiency virus-1 & hepatitis B & C viruses in Indian blood donors,” Indian Journal of Medical Research, vol. 127, no. 2, pp. 140–147, 2008. View at Google Scholar · View at Scopus
  10. “India-2010 Country Progress Report,” UNGASS, India, 2010, http://www.unaids.org/.
  11. M. Summers et al., “Luminogenic reagent using 3-chloro 4-hydroxy acetanilide to enhance peroxidase/luminol chemiluminescence,” Clinical Chemistry, vol. 41, p. S73, 1995. View at Google Scholar
  12. T. Allice, F. Cerutti, F. Pittaluga et al., “COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma,” Journal of Clinical Microbiology, vol. 45, no. 3, pp. 828–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. “Disease burden in India-estimations and causal analysis,” NCMH Background Papers—Burden of Disease in India, http://www.whoindia.org/.
  14. A. Gharehbaghian, “An estimate of transfusion-transmitted infection prevalence in general populations,” Hepatitis Monthly, vol. 11, no. 12, pp. 1002–1003, 2011. View at Publisher · View at Google Scholar
  15. “HIV sentinel surveillance and HIV estimation in India 2007: a technical brief,” National AIDS Control Organisation, Ministry of Health and Family Welfare Government of India, New Delhi, October 2008, http://www.nacoonline.org/.
  16. S. Sood and S. Malvankar, “Seroprevalence of Hepatitis B surface antigen, antibodies to the Hepatitis C virus, and human immunodeficiency virus in a hospital-based population in Jaipur, Rajasthan,” Indian Journal of Community Medicine, vol. 35, no. 1, pp. 165–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. D. L. Tuffanelli, “Ageing and false positive reactions for syphilis,” British Journal of Venereal Diseases, vol. 42, no. 1, pp. 40–41, 1966. View at Google Scholar · View at Scopus
  18. B. Singh, “Nucleic Acid Testing (NAT) screening of blood donors in India,” A Project Report, International Hospital Federation Reference Book, 2008/2009. View at Google Scholar
  19. S. H. Kleinman, D. M. Strong, G. G. E. Tegtmeier et al., “Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test,” Transfusion, vol. 45, no. 8, pp. 1247–1257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. W. K. Roth, M. P. Busch, A. Schuller et al., “International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009,” Vox Sanguinis, vol. 102, pp. 82–90, 2012. View at Publisher · View at Google Scholar
  21. R. Ren, J. X. Wang, Y. Huang et al., “Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase,” Transfusion, vol. 51, no. 12, pp. 2588–2595, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Strobl, “NAT in blood screening around the world,” Medical Laboratory Observer, vol. 43, no. 4, pp. 12–14, 2011. View at Google Scholar · View at Scopus
  23. A. Niemz, T. M. Ferguson, and D. S. Boyle, “Point-of-care nucleic acid testing for infectious diseases,” Trends in Biotechnology, vol. 29, no. 5, pp. 240–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. H. Lee, M. A. Dineva, Y. L. Chua, A. V. Ritchie, I. Ushiro-Lumb, and C. A. Wisniewski, “Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing,” The Journal of Infectious Diseases, vol. 201, supplement 1, pp. S65–S72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Choudhury, S. Tulsiani, P. Desai et al., “Serial follow-up of repeat voluntary blood donors reactive for anti- HCV ELISA,” Asian Journal of Transfusion Science, vol. 5, pp. 26–31, 2011. View at Publisher · View at Google Scholar
  26. E. Kosan, B. Kocazeybek, H. Altunay et al., “Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? A prospective study, the results of 18,200 blood donors from the Turkish Red Crescent,” Transfusion and Apheresis Science, vol. 43, no. 3, pp. 269–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Mine, H. Emura, M. Miyamoto et al., “High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan,” Journal of Virological Methods, vol. 112, no. 1-2, pp. 145–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Vermeulen and R. Reddy, “Current screening strategies for blood donor screening in developing countries,” ISBT Science Series, vol. 5, pp. 308–313, 2010. View at Publisher · View at Google Scholar
  29. N. Gous, L. Scott, O. Perovic, F. Venter, and W. Stevens, “Should South Africa be performing nucleic acid testing on HIV enzyme-linked immunosorbent assay-negative samples?” Journal of Clinical Microbiology, vol. 48, no. 9, pp. 3407–3409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. D. A. Marshall, S. H. Kleinman, J. B. Wong et al., “Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States,” Vox Sanguinis, vol. 86, no. 1, pp. 28–40, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Y. Karris, C. M. Anderson, S. R. Morris et al., “The cost of missing ACUTE HIV Infection: testing antibodies, antigens, and nucleic acids,” Journal of Clinical Microbiology. In press. View at Publisher · View at Google Scholar
  32. B. A. Borkent-Raven, M. P. Janssen, C. L. Van Der Poel, G. A. De Wit, G. J. Bonsel, and B. A. Van Hout, “Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands,” Transfusion, vol. 49, no. 2, pp. 311–319, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. D. Pilcher, J. T. McPherson, P. A. Leone et al., “Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population,” Journal of the American Medical Association, vol. 288, no. 2, pp. 216–220, 2002. View at Google Scholar · View at Scopus
  34. N. Kumarasamy, K. K. Venkatesh, K. H. Mayer, and K. Freedberg, “Financial burden of health services for people with HIV/AIDS in India,” Indian Journal of Medical Research, vol. 126, no. 6, pp. 509–517, 2007. View at Google Scholar · View at Scopus